Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review

References

• Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, Petersen NJ, Nahas Z, Goodnight-White S. Functional impairment in COPD patients: The impact of anxiety and depression. Psychosomatics 2000;41:465–71.
   Google Scholar
• Burns BH, Howell JB. Disproportionately severe breathlessness in chronic bronchitis. Q J Med 1969;38:277–94.
   PubMedGoogle Scholar
• Light RW, Merrill EJ, Despars JA, Gordon GH, Mutalipassi LR. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 1985;87:35–8.
   Google Scholar
• Karajgi B, Rifkin A, Doddi S, Kolli R. The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease. Am J Psychiatry 1990;147:200–1.
   PubMed Web of Science ®Google Scholar
• Dowson C, Laing R, Barraclough R, Town I, Mulder R, Norris K, Drennan C. The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease:a pilot study. NZ Med J 2001;114:447–9.
   Google Scholar
• van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: A systematic review. Thorax 1999;54:688–92.
   Google Scholar
• Isoaho R, Keistinen T, Laippala P, Kivela SL. Chronic obstructive pulmonary disease and symptoms related to depression in elderly persons. Psychol Rep 1995;76:287–97.
   PubMed Web of Science ®Google Scholar
• Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984;144:1613–9.
   Google Scholar
• Engstrom CP, Persson LO, Larsson S, Ryden A, Sullivan M. Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: A descriptive and comparative study. Thorax 1996;51:825–30.
   Google Scholar
• McSweeny AJ, Grant I, Heaton RK, Adams KM, Timms RM. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982;142:473–8.
   Google Scholar
• Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-depen-dent chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2001;21:80–6.
   Google Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: Prevalence, and validation of the BASDEC screening question-naire. Int J Geriatr Psychiatry 2000;15:1090–6.
   Google Scholar
• Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JDJ, Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41:949–58.
   PubMed Web of Science ®Google Scholar
• Stage KB, Middelboe T, Pisinger C. Measurement of depression in patients with chronic obstructive pulmonary disease (COPD). Nordic J Psychiatry 2003;57:297–301.
   Google Scholar
• Yellowlees PM, Alpers JH, Bowden JJ, Bryant GD, Ruffin RE. Psychiatric morbidity in patients with chronic airflow obstruction. Med J Aust 1987;146:305–7.
   Google Scholar
• Porzelius J, Vest M, Nochomovitz M. Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients. Behav Res Ther 1992;30:75–7.
   Google Scholar
• Aghanwa HS, Erhabor GE. Specific psychiatric morbidity among patients with chronic obstructive pulmonary disease in a Nigerian general hospital. J Psychosom Res 2001;50:179–83.
   PubMed Web of Science ®Google Scholar
• Gift AG, Wood RM, Cahill CA. Depression, somatization and steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud 1989;26:281–6.
   Google Scholar
• Nutt D, Ballenger JC, Lepine JP. Panic disorder. Clinical diagnosis, management and mechanisms. London: Martin Dunitz; 1999.
   Google Scholar
• Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis [see comments]. Arch Gen Psychiatry 1993;50:306–17.
   PubMed Web of Science ®Google Scholar
• Grant I, Prigatano GP, Heaton RK, McSweeny AJ, Wright EC, Adams KM. Progressive neuropsychologic impairment and hy-poxemia. Relationship in chronic obstructive pulmonary disease. Arch Gen Psychiatry 1987;44:999–1006.
   Google Scholar
• Borson S, Claypoole K, McDonald GJ. Depression and chronic obstructive pulmonary disease: Treatment trials. Semin Clin Neuropsychiatry 1998;3:115–30.
   Google Scholar
• Breslau N, Kilbey M, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 1991;48:1069–74.
   Google Scholar
• Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symp-toms and psychiatric disorders: Findings from an epidemiologic study of young adults. Am J Psychiatry 1992;149:464–9.
   Google Scholar
• Yohannes AM, Roomi J, Waters K, Connolly MI Quality of life in elderly patients with COPD: Measurement and predictive factors. Respir Med 1998;92:1231–6.
   PubMed Web of Science ®Google Scholar
• Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992;33:190–201.
   PubMed Web of Science ®Google Scholar
• Yellowlees PM. The treatment of psychiatric disorders in patients with chronic airways obstruction. Med J Aust 1987;147:349–52.
   PubMed Web of Science ®Google Scholar
• Light RW, Merrill EJ, Despars J, Gordon GH, Mutalipassi LR. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med 1986;146:1377–80.
   Google Scholar
• Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 1998;39:24–9.
   PubMed Web of Science ®Google Scholar
• Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry 1995;152:1531.
   Google Scholar
• Yohannes AM, Connolly MJ, Baldwin RC. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2001;16:451–4.
   Google Scholar
• Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgo-poulos D. Buspirone effect on breathlessness and exercise perfor-mance in patients with chronic obstructive pulmonary disease. Respiration 1993;60:216–20.
   Google Scholar
• Singh NP, Despars JA, Stansbury DW, Avalos K, Light RW. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 1993;103:800–4.
   Google Scholar
• Eiser N, West C, Evans S, Jeffers A, Quirk F. Effects of psychotherapy in moderately severe COPD: A pilot study. Eur Respir J 1997;10:1581–4.
   Google Scholar
• Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, Orengo CA. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med 2001;31:717–23.
   Google Scholar
• Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol 1998;17:232–40.
   PubMed Web of Science ®Google Scholar
• Aydin 10, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: Applicability of GHQ-12. Gen Hosp Psychiatry 2001;23: 77–83.
   Google Scholar